LONG-TERM SAFETY OF DAROLUTAMIDE AMONG PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WHO RECEIVED MORE THAN 4 YEARS OF THERAPYRobert Hugh Jones,Karim Fizazi,Nicholas D. James,Teuvo L. Tammela,Nobuaki Matsubara,Frank Priou,Phillipe Beuzeboc,Thierry Lesimple,Petri Bono,Vesa Kataja,Jorge A. Garcia,Andrew Protheroe,John Aspegren,Heikki Joensuu,Iris Kuss,Silke Thiele,Sabine Fiala-Buskies,Eglis VjatersJOURNAL OF UROLOGY(2022)引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要